News Archives

News Archives

Avivagen Secures Large OxC-betaTM Livestock Order in Asia

3 tonne order represents a 43% increase over most recent shipment to same customer Growth during pandemic signals strong impact on market share through use of OxC-betaTM Ottawa, ON / Business Wire/ October 18, 2021 / –/ Avivagen Inc.  (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion …Read More

Avivagen to Hold Webcast to Discuss Landmark Deal with AB Vista

AB Vista becomes the exclusive distribution partner for OxC-betaTM for poultry, swine, ruminants (dairy and beef) and aquaculture uses in the United States, Brazil and Thailand Webcast to take place Wednesday, October 6th, 2021, at 10:30 a.m. EST Ottawa, ON /Business Wire/ October 4, 2021/ Avivagen Inc.  (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused …Read More

AB Vista and Avivagen Strike OxC-betaTM Supply Agreement in the United States, Brazil and Thailand

Eight-year agreement expected to increase OxC-BetaTM access and adoption in the largest feed production markets worldwide AB Vista to become exclusive distributor for use with poultry, swine, ruminants and aquaculture in United States, Brazil and Thailand AB Vista and Avivagen to collaborate on development efforts Ottawa, ON/Business Wire/ October 1, 2021/ Leading global animal nutrition …Read More

Avivagen Provides Further Detail on its Third Quarter Results Ending July 31, 2021

Ottawa, ON /Business Wire/ September 30, 2021/ Avivagen Inc.  (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), after releasing its third quarter results yesterday is pleased to provide further detail about product shipments during the third quarter in order to address questions it has received from investors following its earlier press release. The announced 4.4-tonne order for OxC-betaTM Livestock was …Read More

Avivagen Inc. Announces Results for the Third Quarter Ending July 31, 2021

• Total of 8 tonnes in orders secured or shipped during the quarter • Quarter represents more than 43% of 2020 fiscal year Ottawa, ON /Business Wire/ September 29, 2021/ Avivagen Inc.  (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances …Read More

Avivagen Announces Strategic Changes to Support Growth in Asia and South America

Addition of Mr. Lesley Nernberg brings technical sales and marketing expertise to Asia expansion efforts Termination of distribution agreement with São Paulo-based Look Chemicals creates opportunity for accelerated adoption of OxC-betaTM Livestock in Brazil Ottawa, ON /Business Wire/ July 22, 2021/ Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing …Read More